Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Integrating prognostic factors.

G M Clark1

  • 1University of Texas Health Science Center, San Antonio 78284-7884.

Breast Cancer Research and Treatment
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

This study explores evaluating new prognostic factors for breast cancer. Integrating these with traditional factors can improve patient treatment decisions and outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A phase I and pharmacokinetic trial of terephthalamidine (NSC 57155) as a 120-hour continuous infusion.

Investigational new drugs·1998
Same author

Chronic study on the neuronal excitability of the cochlear nuclei of the cat following electrical stimulation.

Acta oto-laryngologica·1998
Same author

Studies of prosody perception by cochlear implant patients.

Audiology : official organ of the International Society of Audiology·1998
Same author

Enzyme-linked immunoabsorbent assay-detected p53 protein accumulation: a prognostic factor in a large breast cancer cohort.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1998
Same author

Modulation detection interference in cochlear implant subjects.

The Journal of the Acoustical Society of America·1998
Same author

Intracellular responses of the rat anteroventral cochlear nucleus to intracochlear electrical stimulation.

Brain research bulletin·1998
Same journal

Comments on: Cost-effectiveness of DPYD genotyping prior to capecitabine administration for metastatic breast cancer.

Breast cancer research and treatment·2026
Same journal

Comments on: Predictors of pathologic complete response in early-stage triple-negative breast cancer treated with neoadjuvant chemo-immunotherapy.

Breast cancer research and treatment·2026
Same journal

Discrimination, spectrum, and clinical utility: ICG lymphography drainage time in axillary staging.

Breast cancer research and treatment·2026
Same journal

Tumor infiltrating lymphocytes (TILs) as a predictive marker of pathological complete response (pCR) in a diverse patient population with early triple negative breast cancer (TNBC) treated with neoadjuvant real-world KEYNOTE-522 regimen.

Breast cancer research and treatment·2026
Same journal

Role of individualized intervention(s) on quality of life and adherence to adjuvant endocrine therapy in premenopausal women with early-stage breast cancer: MyCHOICE study.

Breast cancer research and treatment·2026
Same journal

Subjective socioeconomic status moderates the relationship between objective neighborhood disadvantage and quality of life in middle- and older-aged women with breast cancer.

Breast cancer research and treatment·2026
See all related articles

Area of Science:

  • Oncology
  • Biostatistics

Background:

  • Accurate prognostic factors are crucial for effective breast cancer treatment decisions.
  • Traditional prognostic factors may not capture the full complexity of the disease.

Purpose of the Study:

  • To outline methods for evaluating novel prognostic factors in breast cancer.
  • To discuss the integration of new and traditional prognostic information for improved patient management.

Main Methods:

  • Review of methodologies for prognostic factor evaluation.
  • Discussion on statistical approaches for integrating diverse prognostic data.

Main Results:

  • Established frameworks for assessing the validity and utility of new prognostic markers.
  • Guidelines for combining novel insights with established clinical data.

Related Experiment Videos

Conclusions:

  • New prognostic factors can enhance breast cancer risk stratification.
  • Improved integration of prognostic data leads to more personalized and effective treatment strategies.